Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
Rasmus Rivinius,1 Matthias Helmschrott,1 Arjang Ruhparwar,2 Bastian Schmack,2 Berthold Klein,2 Christian Erbel,1 Christian A Gleissner,1 Mohammadreza Akhavanpoor,1 Lutz Frankenstein,1 Fabrice F Darche,1 Dierk Thomas,1 Philipp Ehlermann,1 Tom Bruckner,3 Hugo A Katus,1 Andreas O Doesch11Department of...
Main Authors: | Rivinius R, Helmschrott M, Ruhparwar A, Schmack B, Klein B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Darche FF, Thomas D, Ehlermann P, Bruckner T, Katus HA, Doesch AO |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-12-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/analysis-of-malignancies-in-patientsnbspafternbspheart-transplantation-peer-reviewed-article-DDDT |
Similar Items
-
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
by: Helmschrott M, et al.
Published: (2015-02-01) -
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
by: Helmschrott M, et al.
Published: (2014-09-01) -
Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
by: Rivinius R, et al.
Published: (2016-02-01) -
The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation
by: Rivinius R, et al.
Published: (2017-03-01) -
COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival
by: Rivinius R, et al.
Published: (2018-09-01)